Combining prolonged-release Metformin Hydrochloride with Glimepiride 2 mg, this formulation is designed to support glycemic control in patients with type 2 diabetes mellitus requiring dual-mechanism therapy.

Each unit of this antidiabetic combination tablet contains Metformin Hydrochloride IP 500 mg (prolonged release) + Glimepiride IP 2 mg, formulated in tablets form and manufactured in compliance with Indian Pharmacopoeia (IP) standards. This ensures uniform potency and quality across every production batch, a key requirement for pharmaceutical importers and distributors evaluating type 2 diabetes management medication for their regional markets.

Indicated for the management of type 2 diabetes mellitus as part of a combination therapy protocol determined by a healthcare provider. Suitable for pharmacy and institutional bulk supply.

Supplied in 10x10 blister strips for secure handling and export transit. The 10x10 Tablets configuration is widely used in international pharmaceutical trade, supporting efficient inventory management for wholesalers and institutional buyers sourcing glimepiride metformin fixed-dose formulation in bulk quantities.

CD&M Remedies is an established manufacturer of IP-compliant pharmaceutical formulations, supplying antidiabetic combination tablet to B2B buyers and importers worldwide. Buyers benefit from consistent formulation quality, reliable supply capability, and export-oriented packing suited to cross-border pharmaceutical trade.

Q: What is the composition of Metformin Hydrochloride Prolonged Release And Glimepiride Tablets IP Cdpride-M2?
A: It contains Metformin Hydrochloride IP 500 mg (prolonged release) + Glimepiride IP 2 mg, manufactured to Indian Pharmacopoeia (IP) standards in tablets form.

Q: What pack sizes are available for Metformin Hydrochloride Prolonged Release And Glimepiride Tablets IP Cdpride-M2?
A: This product is supplied in 10x10 Tablets export packing, suitable for wholesale and institutional bulk orders.

Q: Who manufactures Metformin Hydrochloride Prolonged Release And Glimepiride Tablets IP Cdpride-M2?
A: Metformin Hydrochloride Prolonged Release And Glimepiride Tablets IP Cdpride-M2 is manufactured and supplied by CD&M Remedies, under product code 1006.

Q: Which product category does Metformin Hydrochloride Prolonged Release And Glimepiride Tablets IP Cdpride-M2 belong to?
A: It falls under the Anti-Diabetic Combination Medication category, intended for B2B pharmaceutical buyers and importers.